Development of Simple High Performance Liquid Chromatography for Analysis of Curcumin in Human Plasma In-Vitro
DOI:
https://doi.org/10.35814/jifi.v18i2.947Keywords:
curcumin, irbesartan, HPLC, human plasmaAbstract
Curcumin has antioxidant, antiinfl ammatory, antitumor, apoptotic-inducing, and
antiangiogenesis eff ects. In order to study the pharmacokinetics of curcumin, a method for analysis
of curcumin in plasma levels is required. The aim of this study was developing of a simple High
Performance Liquid Chromatography (HPLC) for analysis curcumin in human plasma in-vitro. The
HPLC system was using isocratic technique in column reversed phase of C18 (Reliant® RP-18e
column (4.6x250 mm; 5 μm)) and mobile phase of acetonitrile–acetic acid–aquabidest (60:1:39) at fl ow
rate of 1.0 mL/min. Irbesartan was used as an internal standard. Detector was performed at a wavelength
of 428 nm for curcumin and 270 nm for irbesartan. Linearity test shown linear results with a correlation
coeffi cient (r) of 0.9970. LLOQ value was 0.0196 μg/mL with a diff erentiation value of 10.48-18.09%.
The accuracy and precision of this method met requirement with a diff erentiation value and relative
standard deviation of between -5.51-3.04 % and 1.04-1.86 %, respectively. Recovery of this method was
94.74-103.12%. This method provides good selectivity for the analysis curcurmin in human plasma.
The developed of HPLC was a simple and valid method for analysis curcumin in human plasma.
References
Downloads
Published
Issue
Section
License
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

















